Literature DB >> 22711543

CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

Anke H Sillars-Hardebol1, Beatriz Carvalho, Jeroen A M Beliën, Meike de Wit, Pien M Delis-van Diemen, Marianne Tijssen, Mark A van de Wiel, Fredrik Pontén, Gerrit A Meijer, Remond J A Fijneman.   

Abstract

BACKGROUND: Gain of chromosome 20q is an important factor in the progression from colorectal adenomas to carcinomas. Genes that drive 20q gain are expected to show correlation of mRNA and protein expression levels with 20q DNA copy number status while functionally influencing cancer processes. CSE1L, DIDO1 and RBM39 are located on the 20q amplicon and affect processes such as cell viability and anchorage-independent growth in colorectal cancer. This study aimed to investigate whether CSE1L, DIDO1 and RBM39 may drive 20q amplification.
METHODS: Protein expression levels were examined by immunohistochemical evaluation of tissue microarrays containing a series of colorectal adenoma and carcinoma samples, which were characterized by genome-wide (microarray-based) DNA and mRNA profiling.
RESULTS: CSE1L, DIDO1 and RBM39 mRNA expression levels correlated with chromosome 20q DNA copy number status. CSE1L protein expression was not associated with 20q gain, although its expression was increased in carcinomas compared to adenomas. DIDO1 and RBM39 protein expression was quite strong in the majority of tumors irrespective of 20q DNA copy number status.
CONCLUSION: The lack of correlation between protein expression levels and 20q DNA copy number status implies that CSE1L, DIDO1 and RBM39 are merely passengers rather than drivers of chromosome 20q gain in colorectal adenoma-to-carcinoma progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22711543     DOI: 10.1007/s13402-012-0088-2

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  49 in total

1.  Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors.

Authors:  Dong-Ju Jung; Soon-Young Na; Doe Sun Na; Jae Woon Lee
Journal:  J Biol Chem       Date:  2001-11-09       Impact factor: 5.157

2.  Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.

Authors:  I M Seiden-Long; K R Brown; W Shih; D A Wigle; N Radulovich; I Jurisica; M-S Tsao
Journal:  Oncogene       Date:  2006-01-05       Impact factor: 9.867

3.  Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability.

Authors:  Varvara Trachana; Karel H M van Wely; Astrid Alonso Guerrero; Agnes Fütterer; Carlos Martínez-A
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

Review 4.  CAS, the human homologue of the yeast chromosome-segregation gene CSE1, in proliferation, apoptosis, and cancer.

Authors:  U Brinkmann
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

5.  High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression.

Authors:  A Wellmann; P Flemming; P Behrens; K Wuppermann; H Lang; K Oldhafer; I Pastan; U Brinkmann
Journal:  Int J Mol Med       Date:  2001-05       Impact factor: 4.101

6.  Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.

Authors:  Remond J A Fijneman; Meike de Wit; Maral Pourghiasian; Sander R Piersma; Thang V Pham; Marc O Warmoes; Mehrdad Lavaei; Chloe Piso; Fiona Smit; Pien M Delis-van Diemen; Sietze T van Turenhout; Jochim S Terhaar sive Droste; Chris J J Mulder; Marinus A Blankenstein; Els C Robanus-Maandag; Ron Smits; Riccardo Fodde; Victor W M van Hinsbergh; Gerrit A Meijer; Connie R Jimenez
Journal:  Clin Cancer Res       Date:  2012-02-20       Impact factor: 12.531

7.  Death inducer-obliterator 1 triggers apoptosis after nuclear translocation and caspase upregulation.

Authors:  David García-Domingo; Dorian Ramírez; Gonzalo González de Buitrago; Carlos Martínez-A
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

8.  Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon.

Authors:  Tang-Yi Tsao; Chin-Shaw Stella Tsai; Jai-Nien Tung; Shun-Liang Chen; Chia-Herng Yue; Ching-Fong Liao; Chi-Chao Wang; Ming-Chung Jiang
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

9.  Morphology, anatomic distribution and cancer potential of colonic polyps.

Authors:  H Shinya; W I Wolff
Journal:  Ann Surg       Date:  1979-12       Impact factor: 12.969

Review 10.  Aneuploidy and cancer.

Authors:  Harith Rajagopalan; Christoph Lengauer
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  17 in total

1.  UHM-ULM interactions in the RBM39-U2AF65 splicing-factor complex.

Authors:  Galina A Stepanyuk; Pedro Serrano; Eigen Peralta; Carol L Farr; Herbert L Axelrod; Michael Geralt; Debanu Das; Hsiu-Ju Chiu; Lukasz Jaroszewski; Ashley M Deacon; Scott A Lesley; Marc-André Elsliger; Adam Godzik; Ian A Wilson; Kurt Wüthrich; Daniel R Salomon; James R Williamson
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-03-24       Impact factor: 7.652

Review 2.  CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

Authors:  Ming-Chung Jiang
Journal:  Tumour Biol       Date:  2016-09-05

3.  Discovering sparse transcription factor codes for cell states and state transitions during development.

Authors:  Leon A Furchtgott; Samuel Melton; Vilas Menon; Sharad Ramanathan
Journal:  Elife       Date:  2017-03-15       Impact factor: 8.140

4.  Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.

Authors:  Jose M Pimiento; Kevin G Neill; Evita Henderson-Jackson; Steven A Eschrich; Dung-Tsa Chen; Kazim Husain; David Shibata; Domenico Coppola; Mokenge P Malafa
Journal:  Am J Pathol       Date:  2016-08-10       Impact factor: 4.307

5.  CAPER, a novel regulator of human breast cancer progression.

Authors:  Isabelle Mercier; Donna M Gonzales; Kevin Quann; Timothy G Pestell; Alexander Molchansky; Federica Sotgia; James Hulit; Ricardo Gandara; Chenguang Wang; Richard G Pestell; Michael P Lisanti; Jean-François Jasmin
Journal:  Cell Cycle       Date:  2014-02-17       Impact factor: 4.534

Review 6.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

Review 7.  RNA Regulators in Leukemia and Lymphoma.

Authors:  Camila Prieto; Michael G Kharas
Journal:  Cold Spring Harb Perspect Med       Date:  2020-05-01       Impact factor: 6.915

8.  The conserved alternative splicing factor caper regulates neuromuscular phenotypes during development and aging.

Authors:  M Brandon Titus; Ethan G Wright; Jeremy M Bono; Andrea K Poliakon; Brandon R Goldstein; Meg K Super; Lauren A Young; Melpomeni Manaj; Morgan Litchford; Noreen E Reist; Darrell J Killian; Eugenia C Olesnicky
Journal:  Dev Biol       Date:  2021-01-27       Impact factor: 3.582

9.  CAPER is vital for energy and redox homeostasis by integrating glucose-induced mitochondrial functions via ERR-α-Gabpa and stress-induced adaptive responses via NF-κB-cMYC.

Authors:  Yun Kyoung Kang; Nagireddy Putluri; Suman Maity; Anna Tsimelzon; Olga Ilkayeva; Qianxing Mo; David Lonard; George Michailidis; Arun Sreekumar; Christopher B Newgard; Meng Wang; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  PLoS Genet       Date:  2015-04-01       Impact factor: 5.917

10.  Reduced rate of copy number aberrations in mucinous colorectal carcinoma.

Authors:  Niek Hugen; Femke Simmer; Leonie J M Mekenkamp; Miriam Koopman; Evert van den Broek; Johannes H W de Wilt; Cornelis J A Punt; Bauke Ylstra; Gerrit A Meijer; Iris D Nagtegaal
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.